- Home
- DCTH vs NCA Comparison
DCTH vs NCA Comparison
Compare DCTH & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- NCA
- Stock Information
- Founded
- DCTH 1988
- NCA 1987
- Country
- DCTH United States
- NCA United States
- Employees
- DCTH N/A
- NCA N/A
- Industry
- DCTH Medical/Dental Instruments
- NCA Investment Managers
- Sector
- DCTH Health Care
- NCA Finance
- Exchange
- DCTH Nasdaq
- NCA Nasdaq
- Market Cap
- DCTH 379.5M
- NCA 288.4M
- IPO Year
- DCTH N/A
- NCA N/A
- Fundamental
- Price
- DCTH $11.87
- NCA $8.73
- Analyst Decision
- DCTH Strong Buy
- NCA
- Analyst Count
- DCTH 4
- NCA 0
- Target Price
- DCTH $21.50
- NCA N/A
- AVG Volume (30 Days)
- DCTH 489.1K
- NCA 59.6K
- Earning Date
- DCTH 11-08-2024
- NCA 01-01-0001
- Dividend Yield
- DCTH N/A
- NCA 3.92%
- EPS Growth
- DCTH N/A
- NCA N/A
- EPS
- DCTH N/A
- NCA N/A
- Revenue
- DCTH $22,644,000.00
- NCA N/A
- Revenue This Year
- DCTH $1,605.13
- NCA N/A
- Revenue Next Year
- DCTH $111.67
- NCA N/A
- P/E Ratio
- DCTH N/A
- NCA N/A
- Revenue Growth
- DCTH 945.91
- NCA N/A
- 52 Week Low
- DCTH $2.84
- NCA $7.77
- 52 Week High
- DCTH $12.88
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- DCTH 61.82
- NCA 41.55
- Support Level
- DCTH $11.42
- NCA $8.64
- Resistance Level
- DCTH $12.79
- NCA $8.82
- Average True Range (ATR)
- DCTH 0.66
- NCA 0.08
- MACD
- DCTH 0.15
- NCA 0.01
- Stochastic Oscillator
- DCTH 74.17
- NCA 47.87
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.